Aperçu rapide pour Drebrin-Like (DBNL) (Middle Region) Peptide (ABIN975606)
Antigène
DBNL
(Drebrin-Like (DBNL))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-DBNL antibody (Catalog #: ARP54437_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
DBNL
Reactivité: Humain, Souris
Hôte: Synthetic
BP, BI
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
DBNL
(Drebrin-Like (DBNL))
Sujet
DBNL is an actin-binding adapter protein. DBNL may act as a common effector of antigen receptor-signaling pathways in leukocytes. Its association with dynamin suggests that it may also connect the actin cytoskeleton to endocytic function. DBNL acts as a k
Alias Symbols: ABP1, HIP-55, SH3P7
Protein Interaction Partner: DBNL,MAP4K1,NEURL4,SH2D4A,SH3BP2,SYK,ZAP70,CASP3,CDK4,CYP4F8,DNPEP,EIF2AK2,GPS2,HERC2,MAP4K1,RB1CC1,SH2D4A,ZAP70